United States

FDA approves Lucentis for diabetic macular edema

Monday, August 13, 2012 10:33 AM

The FDA has approved Genentech’s Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes.

More... »

ADi awarded $2.5M SBIR grant to identify malaria protection biomarkers

Monday, August 13, 2012 10:13 AM

Antigen Discovery (ADi), a biotech based in Irvine, Calif., has received a phase II Small Business Innovation and Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

More... »

Intercept Pharmaceuticals closes $30M Series C financing

Friday, August 10, 2012 03:15 PM

Intercept Pharmaceuticals, a New York-based clinical stage biopharmaceutical company focused on chronic liver diseases, has completed a $30 million Series C preferred stock financing led by OrbiMed Advisors, a global healthcare investment firm, with existing majority investor Genextra of Italy also participating.

More... »

Sen Gillibrand announces bill to spur growth of science and technology jobs

Friday, August 10, 2012 02:58 PM

Sen. Kirsten Gillibrand (D-N.Y.) announced legislation to spur the growth of new science and technology jobs in Western New York and across New York. The “America Innovates Act” would help scientists and researchers secure valuable resources and training to turn their discoveries into marketable products, new high-tech companies and jobs.

More... »

DOD awards Luminex $11.6M to develop biothreat detection tech

Friday, August 10, 2012 02:42 PM

Luminex, a developer and manufacturer of biological testing technologies based in Austin, Texas, has been awarded a contract worth up to $11.6 million over three and a half years by the Department of Defense (DOD).

More... »

CareSouth's expands in Florida, creates jobs in Georgia

Friday, August 10, 2012 12:50 PM

CareSouth Health System, a provider of non-acute care, has expanded its health care services throughout Florida with the purchase of key assets of Alliance Care, a provider of home health care, private duty and physician house call services.

More... »

CDC grants $4.1M to WVU for injury control research

Friday, August 10, 2012 12:41 PM

The Centers for Disease Control and Prevention (CDC) has awarded the West Virginia University Injury Control Research Center (ICRC) a five-year grant totaling $4.1 million to continue as one of 11 such federally funded centers of excellence for injury prevention research, education and outreach in the nation.

More... »

Galenea, CHDI Foundation expand Huntington's disease collaboration

Friday, August 10, 2012 10:20 AM

Galenea, a Cambridge, Mass.-based company focused on synaptic transmission drug discovery, and CHDI Foundation, a not-for-profit, biomedical research organization focused on Huntington’s disease (HD), have extended and expanded their collaboration to further characterize the synaptic dysfunction apparent in HD utilizing Galenea’s proprietary platform.

More... »

Nile Therapeutics promotes Horton to president, CEO, director

Thursday, August 9, 2012 03:06 PM

Nile Therapeutics, a San Mateo, Calif.-based biopharmaceutical company that develops novel therapeutics for heart failure, has promoted Darlene Horton, M.D. to president, CEO and director of the company.

More... »

FDA approves Marqibo for rare type of leukemia

Thursday, August 9, 2012 02:56 PM

The FDA approved Talon Therapeutics’ Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL), a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.

More... »